Sep 30, 2021

Arcturus Therapeutics Q3 2021 Earnings Report

Total Revenue
$2.44M
Previous year: $2.33M
+4.5%
EPS
-$2.05
Previous year: -$0.92
+122.8%
Gross Profit
$2.44M
Cash and Equivalents
$414M
Free Cash Flow
-$18.4M
Total Assets
$435M

Arcturus Therapeutics

Arcturus Therapeutics